Bone marrow angiogenesis and plasma cell angiogenic and invasive potential in patients with active multiple myeloma

Angelo Vacca, Domenico Ribatti, Aldo M. Roccaro, Roberto Ria, Loredana Palermo, Franco Dammacco

Research output: Contribution to journalArticle

Abstract

Factor VIII-related antigen-positive microvessel areas were measured by both immunohistochemistry and computerized image analysis in patients with active multiple myeloma (MM), nonactive MM and monoclonal gammopathies of undetermined significance (MGUS). A 5- to 6-fold larger area was found in patients with active MM compared to the other two groups. The conditioned medium (CM) of their bone marrow plasma cells stimulated endothelial cell proliferation and chemotaxis, monocyte chemotaxis and angiogenesis in vivo [chick embryo chorioallantoic membrane (CAM) system] more strongly and frequently than the CM of patients with nonactive MM and MGUS. An immunoassay of plasma cell lysates gave significantly higher levels of fibroblast growth factor-2 (FGF-2) in patients with active MM than in the other two groups, and a neutralizing anti-FGF-2 antibody inhibited by 54-68% the biological activity exerted by the CM in vitro and in the CAM. In situ hybridization of bone marrow plasma cells and gelatin zymography of CM showed that patients with active MM express higher levels of matrix metalloproteinase-2 (MMP-2) mRNA and protein than those with nonactive MM and MGUS, whereas MMP-9 expression and secretion overlapped in all groups. Overall data suggest that patients with active MM represent the vascular phase of plasma cell tumors that is triggered by bone marrow plasma cells, at least partly, through FGF-2 and MMP-2. Both angiogenesis and MMP-2 secretion can account for intramedullary and extramedullary spreading of plasma cells during the active MM.

Original languageEnglish
Pages (from-to)162-169
Number of pages8
JournalActa Haematologica
Volume106
Issue number4
DOIs
Publication statusPublished - 2001

Fingerprint

Plasma Cells
Multiple Myeloma
Bone Marrow Cells
Monoclonal Gammopathy of Undetermined Significance
Conditioned Culture Medium
Matrix Metalloproteinase 2
Fibroblast Growth Factor 2
Chorioallantoic Membrane
Chemotaxis
Plasmacytoma
von Willebrand Factor
Chick Embryo
Gelatin
Microvessels
Matrix Metalloproteinases
Immunoassay
In Situ Hybridization
Blood Vessels
Monocytes
Endothelial Cells

Keywords

  • Angiogenesis
  • Endothelial cell
  • Invasion
  • Metalloproteinases
  • Multiple myeloma
  • Tumor progression

ASJC Scopus subject areas

  • Hematology

Cite this

Bone marrow angiogenesis and plasma cell angiogenic and invasive potential in patients with active multiple myeloma. / Vacca, Angelo; Ribatti, Domenico; Roccaro, Aldo M.; Ria, Roberto; Palermo, Loredana; Dammacco, Franco.

In: Acta Haematologica, Vol. 106, No. 4, 2001, p. 162-169.

Research output: Contribution to journalArticle

Vacca, Angelo ; Ribatti, Domenico ; Roccaro, Aldo M. ; Ria, Roberto ; Palermo, Loredana ; Dammacco, Franco. / Bone marrow angiogenesis and plasma cell angiogenic and invasive potential in patients with active multiple myeloma. In: Acta Haematologica. 2001 ; Vol. 106, No. 4. pp. 162-169.
@article{2ff9ba314979415ba0f825c27554594f,
title = "Bone marrow angiogenesis and plasma cell angiogenic and invasive potential in patients with active multiple myeloma",
abstract = "Factor VIII-related antigen-positive microvessel areas were measured by both immunohistochemistry and computerized image analysis in patients with active multiple myeloma (MM), nonactive MM and monoclonal gammopathies of undetermined significance (MGUS). A 5- to 6-fold larger area was found in patients with active MM compared to the other two groups. The conditioned medium (CM) of their bone marrow plasma cells stimulated endothelial cell proliferation and chemotaxis, monocyte chemotaxis and angiogenesis in vivo [chick embryo chorioallantoic membrane (CAM) system] more strongly and frequently than the CM of patients with nonactive MM and MGUS. An immunoassay of plasma cell lysates gave significantly higher levels of fibroblast growth factor-2 (FGF-2) in patients with active MM than in the other two groups, and a neutralizing anti-FGF-2 antibody inhibited by 54-68{\%} the biological activity exerted by the CM in vitro and in the CAM. In situ hybridization of bone marrow plasma cells and gelatin zymography of CM showed that patients with active MM express higher levels of matrix metalloproteinase-2 (MMP-2) mRNA and protein than those with nonactive MM and MGUS, whereas MMP-9 expression and secretion overlapped in all groups. Overall data suggest that patients with active MM represent the vascular phase of plasma cell tumors that is triggered by bone marrow plasma cells, at least partly, through FGF-2 and MMP-2. Both angiogenesis and MMP-2 secretion can account for intramedullary and extramedullary spreading of plasma cells during the active MM.",
keywords = "Angiogenesis, Endothelial cell, Invasion, Metalloproteinases, Multiple myeloma, Tumor progression",
author = "Angelo Vacca and Domenico Ribatti and Roccaro, {Aldo M.} and Roberto Ria and Loredana Palermo and Franco Dammacco",
year = "2001",
doi = "10.1159/000046612",
language = "English",
volume = "106",
pages = "162--169",
journal = "Acta Haematologica",
issn = "0001-5792",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Bone marrow angiogenesis and plasma cell angiogenic and invasive potential in patients with active multiple myeloma

AU - Vacca, Angelo

AU - Ribatti, Domenico

AU - Roccaro, Aldo M.

AU - Ria, Roberto

AU - Palermo, Loredana

AU - Dammacco, Franco

PY - 2001

Y1 - 2001

N2 - Factor VIII-related antigen-positive microvessel areas were measured by both immunohistochemistry and computerized image analysis in patients with active multiple myeloma (MM), nonactive MM and monoclonal gammopathies of undetermined significance (MGUS). A 5- to 6-fold larger area was found in patients with active MM compared to the other two groups. The conditioned medium (CM) of their bone marrow plasma cells stimulated endothelial cell proliferation and chemotaxis, monocyte chemotaxis and angiogenesis in vivo [chick embryo chorioallantoic membrane (CAM) system] more strongly and frequently than the CM of patients with nonactive MM and MGUS. An immunoassay of plasma cell lysates gave significantly higher levels of fibroblast growth factor-2 (FGF-2) in patients with active MM than in the other two groups, and a neutralizing anti-FGF-2 antibody inhibited by 54-68% the biological activity exerted by the CM in vitro and in the CAM. In situ hybridization of bone marrow plasma cells and gelatin zymography of CM showed that patients with active MM express higher levels of matrix metalloproteinase-2 (MMP-2) mRNA and protein than those with nonactive MM and MGUS, whereas MMP-9 expression and secretion overlapped in all groups. Overall data suggest that patients with active MM represent the vascular phase of plasma cell tumors that is triggered by bone marrow plasma cells, at least partly, through FGF-2 and MMP-2. Both angiogenesis and MMP-2 secretion can account for intramedullary and extramedullary spreading of plasma cells during the active MM.

AB - Factor VIII-related antigen-positive microvessel areas were measured by both immunohistochemistry and computerized image analysis in patients with active multiple myeloma (MM), nonactive MM and monoclonal gammopathies of undetermined significance (MGUS). A 5- to 6-fold larger area was found in patients with active MM compared to the other two groups. The conditioned medium (CM) of their bone marrow plasma cells stimulated endothelial cell proliferation and chemotaxis, monocyte chemotaxis and angiogenesis in vivo [chick embryo chorioallantoic membrane (CAM) system] more strongly and frequently than the CM of patients with nonactive MM and MGUS. An immunoassay of plasma cell lysates gave significantly higher levels of fibroblast growth factor-2 (FGF-2) in patients with active MM than in the other two groups, and a neutralizing anti-FGF-2 antibody inhibited by 54-68% the biological activity exerted by the CM in vitro and in the CAM. In situ hybridization of bone marrow plasma cells and gelatin zymography of CM showed that patients with active MM express higher levels of matrix metalloproteinase-2 (MMP-2) mRNA and protein than those with nonactive MM and MGUS, whereas MMP-9 expression and secretion overlapped in all groups. Overall data suggest that patients with active MM represent the vascular phase of plasma cell tumors that is triggered by bone marrow plasma cells, at least partly, through FGF-2 and MMP-2. Both angiogenesis and MMP-2 secretion can account for intramedullary and extramedullary spreading of plasma cells during the active MM.

KW - Angiogenesis

KW - Endothelial cell

KW - Invasion

KW - Metalloproteinases

KW - Multiple myeloma

KW - Tumor progression

UR - http://www.scopus.com/inward/record.url?scp=0035708060&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035708060&partnerID=8YFLogxK

U2 - 10.1159/000046612

DO - 10.1159/000046612

M3 - Article

C2 - 11815713

AN - SCOPUS:0035708060

VL - 106

SP - 162

EP - 169

JO - Acta Haematologica

JF - Acta Haematologica

SN - 0001-5792

IS - 4

ER -